The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma

• Published in: Swiss medical weekly Vol. 146; no. 708; p. w14279
• Main Authors: Dummer, Reinhard, Siano, Marco, Hunger, Robert E., Lindenblatt, Nicole, Braun, Ralph, Michielin, Oliver, Mihic-Probst, Daniela, Von Moos, Roger, Najafi, Yousef, Guckenberger, Matthias, Arnold, Andreas
• Format: Journal Article
• Language: English
• Published: Switzerland SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2016
• Subjects: Antibodies, Monoclonal - therapeutic use; Antineoplastic Agents - therapeutic use; Chemotherapy, Adjuvant; Dacarbazine - analogs & derivatives; Dacarbazine - therapeutic use; Dermatologic Surgical Procedures; follow-up; Guidelines; Humans; Imidazoles - therapeutic use; Indoles - therapeutic use; Ipilimumab; Lymph Node Excision; Melanoma; Melanoma - pathology; Melanoma - therapy; Neoplasm Staging; Oximes - therapeutic use; Practice Guidelines as Topic; Radiotherapy, Adjuvant; Sentinel Lymph Node Biopsy; Skin Neoplasms - pathology; Skin Neoplasms - therapy; Staging; Sulfonamides - therapeutic use; Switzerland; therapy
• ISSN: 1424-3997; 1424-3997
• DOI: 10.4414/smw.2016.14279

Cutaneous melanoma is the most deadly cutaneous neoplasm. In order to guide treatment decisions and follow-up of melanoma patients, guidelines for the management of melanoma in Switzerland were inaugurated in 2001 and revised in 2006 and 2016. Recent data on surgical and medical treatments from randomised trials necessitated modification of the treatment and follow-up recommendations.